Misplaced Pages

Fenpiprane: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 19:56, 28 December 2022 editRowanJ LP (talk | contribs)Extended confirmed users, Pending changes reviewers2,297 editsNo edit summaryTags: Visual edit Newcomer task Newcomer task: references← Previous edit Revision as of 20:35, 28 December 2022 edit undoBoghog (talk | contribs)Autopatrolled, Extended confirmed users, IP block exemptions, New page reviewers, Pending changes reviewers, Rollbackers, Template editors137,805 edits consistent citation formattingNext edit →
Line 46: Line 46:
}} }}


'''Fenpiprane''' is a drug used for ]s.<ref>{{Cite journal |last=Whitfield |first=Lynette K. |last2=Shulman |first2=Robert J. |date=May 1, 2010 |title=Treatment Options for Functional Gastrointestinal Disorders: From Empiric to Complementary Approaches |url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2830707/ |journal=HHS Author Manuscripts |volume=38 |issue=5 |pages=8 |pmc=PMC2830707 |pmid=19476303 |via=]}}</ref><ref>{{Cite journal |last=Black |first=Christopher J. |last2=Drossman |first2=Douglas A. |last3=Talley |first3=Nicholas J. |last4=Ruddy |first4=Johannah |last5=Ford |first5=Alexander C. |date=2020-11-21 |title=Functional gastrointestinal disorders: advances in understanding and management |url=https://pubmed.ncbi.nlm.nih.gov/33049221/ |journal=Lancet (London, England) |volume=396 |issue=10263 |pages=1664–1674 |doi=10.1016/S0140-6736(20)32115-2 |issn=1474-547X |pmid=33049221}}</ref><ref>{{Cite journal |last=Olden |first=Kevin W. |date=November 7, 2014 |title=The use of antidepressants in functional gastrointestinal disorders: new uses for old drugs |url=https://pubmed.ncbi.nlm.nih.gov/16273017/ |journal=CNS spectrums |volume=10 |issue=11 |pages=891–896 |doi=10.1017/s1092852900019866 |issn=1092-8529 |pmid=16273017 |via=]}}</ref> '''Fenpiprane''' is a drug used for ]s.<ref>{{cite journal | vauthors = Whitfield KL, Shulman RJ | title = Treatment options for functional gastrointestinal disorders: from empiric to complementary approaches | journal = Pediatric Annals | volume = 38 | issue = 5 | pages = 288-90, 292-4 | date = May 2009 | pmid = 19476303 | pmc = 2830707 }}</ref><ref>{{cite journal | vauthors = Black CJ, Drossman DA, Talley NJ, Ruddy J, Ford AC | title = Functional gastrointestinal disorders: advances in understanding and management | journal = Lancet | volume = 396 | issue = 10263 | pages = 1664–1674 | date = November 2020 | pmid = 33049221 | doi = 10.1016/S0140-6736(20)32115-2 | s2cid = 222253972 | url = https://eprints.whiterose.ac.uk/166984/3/THELANCET-D-20-00966R3%20CLEAN.pdf }}</ref><ref>{{cite journal | vauthors = Olden KW | title = The use of antidepressants in functional gastrointestinal disorders: new uses for old drugs | journal = CNS Spectrums | volume = 10 | issue = 11 | pages = 891–896 | date = November 2005 | pmid = 16273017 | doi = 10.1017/s1092852900019866 | s2cid = 416219 }}</ref>


== References == == References ==



] ]

Revision as of 20:35, 28 December 2022

Chemical compound
This article provides insufficient context for those unfamiliar with the subject. Please help improve the article by providing more context for the reader. (May 2014) (Learn how and when to remove this message)
Pharmaceutical compound
Fenpiprane
Clinical data
ATC code
Identifiers
IUPAC name
  • 1-piperidine
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC20H25N
Molar mass279.427 g·mol
3D model (JSmol)
SMILES
  • C1CCN(CC1)CCC(C2=CC=CC=C2)C3=CC=CC=C3
InChI
  • InChI=1S/C20H25N/c1-4-10-18(11-5-1)20(19-12-6-2-7-13-19)14-17-21-15-8-3-9-16-21/h1-2,4-7,10-13,20H,3,8-9,14-17H2
  (verify)

Fenpiprane is a drug used for functional gastrointestinal disorders.

References

  1. Whitfield KL, Shulman RJ (May 2009). "Treatment options for functional gastrointestinal disorders: from empiric to complementary approaches". Pediatric Annals. 38 (5): 288–90, 292–4. PMC 2830707. PMID 19476303.
  2. Black CJ, Drossman DA, Talley NJ, Ruddy J, Ford AC (November 2020). "Functional gastrointestinal disorders: advances in understanding and management" (PDF). Lancet. 396 (10263): 1664–1674. doi:10.1016/S0140-6736(20)32115-2. PMID 33049221. S2CID 222253972.
  3. Olden KW (November 2005). "The use of antidepressants in functional gastrointestinal disorders: new uses for old drugs". CNS Spectrums. 10 (11): 891–896. doi:10.1017/s1092852900019866. PMID 16273017. S2CID 416219.
Stub icon

This drug article relating to the gastrointestinal system is a stub. You can help Misplaced Pages by expanding it.

Drugs for functional gastrointestinal disorders (A03)
Drugs for
functional
bowel
disorders
Antimuscarinics
Tertiary
amino group
Quaternary
ammonium
compounds
Phosphodiesterase
inhibitors
Acting on
serotonin receptors
Other
Belladonna
and derivatives
(antimuscarinics)
Propulsives
Categories: